Description
Competitive inhibitors of HMG-CoA reductase are the rate limiting enzymes in cholesterol biosynthesis.. By blocking the conversion of HMG-CoA to the cholesterol precursor mevalonate, these agents inhibit hepatic synthesis of cholesterol, causing a subsequent stimulation of LDL receptors and an increase in the clearance of LDL. Pkg: 25 mL